FDA Inspection 1033906 — GERI-GENTLE CORPORATION

GERI-GENTLE CORPORATION — FEI 3012227494

The FDA completed an inspection of GERI-GENTLE CORPORATION on Dec 4, 2017 in South Plainfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 4, 2017
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
South Plainfield, NJ (United States)

Citations

IDCFRDescription
1471021 CFR 820.150Lack of or inadequate procedures for storage.
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.